Exagen Inc. (XGN) Revenue Growth
Exagen Inc. (XGN) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2020-12-31 | 3.93% |
| 2021-12-31 | 15.07% |
| 2022-12-31 | -5.66% |
| 2023-12-31 | 15.33% |
| 2024-12-31 | 5.89% |
| 2025-12-31 | 19.65% |
How XGN compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| ENSG | The Ensign Group Inc. | 18.72% |
| PEN | Penumbra Inc. | 17.50% |
| VCYT | Veracyte Inc. | 16.01% |
| ATRC | AtriCure Inc. | 14.88% |
| BMRN | BioMarin Pharmaceutical Inc. | 12.87% |
These are five companies in the same sector as XGN with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Exagen Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("XGN", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | XGN | $7.58 | +0.53% | 0.14M |
| 3 | ||||
| 4 | ||||
| 5 |